Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy (Q43221783)
Jump to navigation
Jump to search
scientific article published on 10 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy |
scientific article published on 10 December 2009 |
Statements
1 reference
Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy (English)
1 reference
1 reference
T P Hughes
1 reference
D K Hiwase
1 reference
S Zrim
1 reference
V Saunders
1 reference
J V Melo
1 reference
10 December 2009
1 reference
1 reference
24
1 reference
3
1 reference
658-660
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference